OncoKB: A Precision Oncology Knowledge BaseDebyani Chakravarty, Nikolaus Schultz, Jianjiong Gao et al.|JCO Precision Oncology|2017Cited by 2.7k
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyJordi Barretina, Samuel Singer, John E. Major et al.|Nature Genetics|2010Cited by 725
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint BlockadeWassim Abida, Howard I. Scher, Joshua Armenia et al.|JAMA Oncology|2018Cited by 661
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision MakingWassim Abida, Howard I. Scher, Joshua Armenia et al.|JCO Precision Oncology|2017Cited by 529
The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective mannerEric W. Joseph, Neal Rosen, Christine A. Pratilas et al.|Proceedings of the National Academy of Sciences|2010Cited by 447